Evotec stock: JPMorgan disclosure adds focus before results
Published on 10/30/2026 at 16:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSOwnership filing and results outlook
- JPMorgan's combined position includes voting rights attached to shares and positions held through instruments.
- The threshold event occurred on October 23, while the notification was published on October 29.
- Evotec will release its first nine-month results and provide a business update on November 5.
JPMorgan Chase & Co. disclosed a changed combined position in Evotec on October 29, according to AD HOC NEWS. The filing adds a fresh ownership signal before the company's next scheduled operating update.
Ownership filing changes the picture
The combined position consists of voting rights attached to shares and holdings through instruments. The threshold event occurred on October 23, while the notification was published six days later.
The filing lists 3.86 percent of voting rights attached to shares and 2.69 percent through instruments. JPMorgan Chase & Co. is identified as the notifying legal entity, with the disclosure described as a voluntary group notification triggered at subsidiary level.
Results remain the next catalyst
Evotec is scheduled to publish its first nine-month 2026 results and provide a business update on Thursday, November 5. The company plans an English-language webcast and conference call at 2:00 p.m. CET, giving investors the next formal review of operating performance after the preliminary nine-month figures and unchanged full-year outlook announced earlier in October.
Share price moves below Xetra close
Evotec stock traded at EUR 2.85 on Lang & Schwarz at 16:07 CEST on Friday, October 30, 2026, 2.73 percent below the Xetra close of Thursday, October 29. Compared with the EUR 2.94 Lang & Schwarz quote in the October 29 report, the price was 3.06 percent lower. These comparisons do not establish a causal link between the ownership filing and the share-price movement.
For a live update, see the real-time quote of Evotec stock.
Evotec SE key data
- Company: Evotec SE
- ISIN: DE0005664809
- WKN: 566480
- Frankfurt ticker: EVT
- Xetra ticker: EVT.DE
- Reported Lang & Schwarz quote: EUR 2.85 on October 30, 2026 at 16:07 CEST
- Xetra reference: EUR 2.93 closing price on October 29, 2026
- Sector: Health Care
- Indices: SDAX and TecDAX
Germany's broader market setting can be followed through the DAX market theme.
